Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Place of HSCT in treatment of childhood AML

Abstract

This short review focuses on the role of hematopoietic SCT (HSCT) in childhood AML. In first CR (CR1), some studies demonstrate superiority of allogeneic HSCT with HLA identical sibling donors over the continuation of chemotherapy and others did not. The studies differ in regard to the included risk categories of patients and the outcome niveau of the chemotherapy arm. The BFM98 study found no benefit in having a donor, in particular in terms of overall survival. Autologous HSCT in CR1 is not superior in any of the reviewed trials over the continuation of chemotherapy. In second CR, evidence for the function of allogeneic HSCT is small. However, published data and evidence-based reports recommend an unrelated or related transplantation in the situation of a renewed remission. Data on haploidentical HSCT and on cord blood HSCT are still lacking in the case of AML. Combined studies of larger study groups are warranted to broaden the data basis for rational decision.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 2007; 13: 1–25.

    Article  Google Scholar 

  2. Ortega JJ, Diaz de Heredia C, Olive T, Bastida P, Llort A, Armadans L et al. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Haematologica 2003; 88: 290–299.

    PubMed  Google Scholar 

  3. Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood 2001; 97: 56–62.

    Article  CAS  Google Scholar 

  4. Stevens RF, Hann IM, Wheatley K, Gray RG . Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 1998; 101: 130–140.

    Article  CAS  Google Scholar 

  5. Bleakley M, Lau L, Shaw PJ, Kaufman A . Bone marrow transplantation for paediatric AML in first remission: a systematic review and meta-analysis. Bone Marrow Transplant 2002; 29: 843–852.

    Article  CAS  Google Scholar 

  6. Alonzo TA, Wells RJ, Woods WG, Lange B, Gerbing RB, Buxton AB et al. Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era. Leukemia 2005; 19: 965–970.

    Article  CAS  Google Scholar 

  7. Reinhardt D, Kremens B, Zimmermann M, Vormoor J, Dworzak M, Peters C et al. No improvement of overall-survival in children with high-risk acute myeloid leukemia by stem cell transplantation in 1st complete remission. Blood 2006; 108: 99a.

    Google Scholar 

  8. Lange BJ, Smith FO, Feusner J, Barnard DR, Dinndorf P, Feig S et al. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood 2008; 111: 1044–1053.

    Article  CAS  Google Scholar 

  9. Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N, Loffler H et al. Definition of a standard-risk group in children with AML. Br J Haematol 1999; 104: 630–639.

    Article  CAS  Google Scholar 

  10. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.

    CAS  PubMed  Google Scholar 

  11. Wells RJ, Adams MT, Alonzo TA, Arceci RJ, Buckley J, Buxton AB et al. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. J Clin Oncol 2003; 21: 2940–2947.

    Article  CAS  Google Scholar 

  12. Aversa F, Reisner Y, Martelli MF . The haploidentical option for high-risk haematological malignancies. Blood Cells Mol Dis 2008; 40: 8–12.

    Article  Google Scholar 

  13. Bader P, Willasch A, Niethammer D, Klingebiel T . Haploidentical stem cell transplantation in childhood. Current Cancer Therapy Reviews 2007; 3: 37–44.

    Article  Google Scholar 

  14. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group Analysis. Blood 2003; 102: 4290–4297.

    Article  CAS  Google Scholar 

  15. Creutzig U, Reinhardt D, Zimmermann M, Klingebiel T, Gadner H . Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies. Blood 2001; 97: 3671–3672; author reply 3674-3675.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to T Klingebiel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klingebiel, T., Reinhardt, D., Bader, P. et al. Place of HSCT in treatment of childhood AML. Bone Marrow Transplant 42 (Suppl 2), S7–S9 (2008). https://doi.org/10.1038/bmt.2008.276

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.276

Keywords

This article is cited by

Search

Quick links